A phase II study of carboplatin and vincristine in previously treated patients with small-cell lung cancer

@article{Smit1989API,
  title={A phase II study of carboplatin and vincristine in previously treated patients with small-cell lung cancer},
  author={Egbert F. Smit and Henk H. Berendsen and Elisabeth G. E. de Vries and Nanno H. Mulder and Pieter E. Postmus},
  journal={Cancer Chemotherapy and Pharmacology},
  year={1989},
  volume={25},
  pages={202-204}
}
A total of 28 previously treated patients with small-cell lung cancer were treated at relapse with 400 mg/m2 carboplatin and 2 mg vincristine on days 1 and 8, every 4 weeks. Ten partial responses (PRs) (37%) but no complete responses (CRs) were seen. Median survival after the start of second-line treatment was 120 days (range, 39–503 days). Toxicity of this… CONTINUE READING